Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2007 3
2008 3
2009 3
2010 4
2011 4
2012 1
2013 4
2014 2
2015 3
2016 5
2017 5
2018 6
2019 2
2020 1
2021 6
2022 3
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
[Molecular diagnostics for vitreoretinal lymphoma].
Bonzheim I, Salmerón-Villalobos J, Süsskind D, Szurman P, Gekeler F, Spitzer MS, Salaverria I, Campo E, Coupland SE, Quintanilla-Martinez L, Fend F. Bonzheim I, et al. Among authors: susskind d. Pathologie (Heidelb). 2023 Dec;44(Suppl 3):150-154. doi: 10.1007/s00292-023-01251-z. Epub 2023 Nov 10. Pathologie (Heidelb). 2023. PMID: 37947807 Review. German.
[Malignant lymphomas of the eye].
Fend F, Süsskind D, Deuter C, Coupland SE. Fend F, et al. Among authors: susskind d. Pathologe. 2017 Nov;38(6):515-520. doi: 10.1007/s00292-017-0378-6. Pathologe. 2017. PMID: 28993856 Review. German.
["Loose eye"].
Rohrbach JM, Süsskind D, Reinthal E, Weidle EG, Necker HP. Rohrbach JM, et al. Among authors: susskind d. Ophthalmologe. 2009 Jun;106(6):551-3. doi: 10.1007/s00347-008-1891-z. Ophthalmologe. 2009. PMID: 19083244 German.
NF1 mutations in conjunctival melanoma.
Scholz SL, Cosgarea I, Süßkind D, Murali R, Möller I, Reis H, Leonardelli S, Schilling B, Schimming T, Hadaschik E, Franklin C, Paschen A, Sucker A, Steuhl KP, Schadendorf D, Westekemper H, Griewank KG. Scholz SL, et al. Among authors: susskind d. Br J Cancer. 2018 May;118(9):1243-1247. doi: 10.1038/s41416-018-0046-5. Epub 2018 Mar 21. Br J Cancer. 2018. PMID: 29559732 Free PMC article.
The molecular hallmarks of primary and secondary vitreoretinal lymphoma.
Bonzheim I, Sander P, Salmerón-Villalobos J, Süsskind D, Szurman P, Gekeler F, Spitzer MS, Steinhilber J, Kohler E, Büssgen M, Schittenhelm J, Salaverria I, Campo E, Coupland SE, Quintanilla-Martinez L, Fend F. Bonzheim I, et al. Among authors: susskind d. Blood Adv. 2022 Mar 8;6(5):1598-1607. doi: 10.1182/bloodadvances.2021004212. Blood Adv. 2022. PMID: 34448823 Free PMC article.
Assessment of Retinopathy of Prematurity Regression and Reactivation Using an Artificial Intelligence-Based Vascular Severity Score.
Eilts SK, Pfeil JM, Poschkamp B, Krohne TU, Eter N, Barth T, Guthoff R, Lagrèze W, Grundel M, Bründer MC, Busch M, Kalpathy-Cramer J, Chiang MF, Chan RVP, Coyner AS, Ostmo S, Campbell JP, Stahl A; Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity (CARE-ROP) Study Group. Eilts SK, et al. JAMA Netw Open. 2023 Jan 3;6(1):e2251512. doi: 10.1001/jamanetworkopen.2022.51512. JAMA Netw Open. 2023. PMID: 36656578 Free PMC article. Clinical Trial.
Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3.
Eichholz T, Heubach F, Arendt AM, Seitz C, Brecht IB, Ebinger M, Flaadt T, Süsskind D, Richter L, Hülsenbeck I, Zerweck L, Göricke S, Paulsen F, Dombrowski F, Flotho C, Schönberger S, Ketteler P, Schulte J, Lang P. Eichholz T, et al. Among authors: susskind d. Cancer Immunol Immunother. 2024 Jan 19;73(1):19. doi: 10.1007/s00262-023-03587-0. Cancer Immunol Immunother. 2024. PMID: 38240863 Free PMC article.
55 results